Antibiotice Ia (ATB) — Financial Flexibility Index

Latest as of December 2025: 0.11x

Antibiotice Ia (ATB) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of RON50.94 Million (operating CF RON37.61 Million minus capex RON13.33 Million) represents 0% of total liabilities (RON460.49 Million). Also explore Antibiotice Ia (ATB) equity growth momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.11x
Free Cash Flow / Total Liabilities

Free Cash Flow

RON50.94 Million
Operating CF − Capex

Total Liabilities

RON460.49 Million
RON

Capital Expenditures

RON13.33 Million
RON

Antibiotice Ia Financial Flexibility Index (2022–2025)

Historical Financial Flexibility Index trend for Antibiotice Ia across 4 annual periods. See ATB equity to assets ratio to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for Antibiotice Ia (2022–2025)

Year-by-year free cash flow to debt coverage for Antibiotice Ia. For the full company profile including market capitalisation, see Antibiotice Ia market cap and net worth.

Year Flexibility Index Free Cash Flow (RON) Operating CF Total Liabilities YoY Change
2025 0.47x RON215.05 Million RON72.44 Million RON460.49 Million ▼ -14.9%
2024 0.55x RON211.31 Million RON95.15 Million RON384.95 Million ▼ -27.3%
2023 0.75x RON220.50 Million RON122.46 Million RON292.21 Million ▲ +4.3%
2022 0.72x RON155.54 Million RON115.66 Million RON215.04 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities